Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Northern Ireland
76%
Clinical Proteomics
54%
Clinical Genomics
54%
Proteomic Markers
54%
Machine Learning Algorithms
54%
Clinical Markers
54%
Genomic Markers
54%
COVID-19
45%
Islet
38%
Receptor Signaling
36%
Comorbidity
36%
Obesity Diabetes
36%
Non-responders
34%
Genomics-proteomics
30%
Glucagon-like peptide-1 Receptor (GLP-1R)
30%
Age Groups
30%
Glycemic Control
30%
Plasma Proteins
29%
Incident Type 2 Diabetes
27%
Lipid Control
27%
Simvastatin
27%
Atorvastatin
27%
Phenotypic Biomarkers
27%
Proteomic Biomarkers
27%
Retrospective Observational Study
27%
APP Mice
27%
Extrapancreatic
27%
SARS-CoV-2 Antibodies
27%
Anti-SARS-CoV-2
27%
Glucose Uptake
27%
Antibody Seroprevalence
27%
Glucose-dependent Insulinotropic Polypeptide
27%
3T3-L1 Adipocytes
27%
Xenin-25
27%
Multiple Morbidity
27%
Biochip Technology
27%
Unimolecular
27%
Exendin-4 (Ex-4)
27%
CCK Receptors
27%
Liverpool
27%
Metformin Monotherapy
27%
Disease Management
27%
Fracture Risk
27%
Insulin Signaling
27%
Population-based Study
27%
Glucose Effect
27%
Severe COVID-19
27%
COVID-19 Severity
27%
Signal Functions
27%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
54%
Pancreatic Islet
31%
Diabetes
29%
Arm
27%
Population Research
27%
Fracture
27%
Emergency Department
27%
Chronic Kidney Disease
27%
Acute Renal Failure
27%
Biochip
27%
Primary Health Care
27%
Multiple Morbidities
27%
Glucagon Like Peptide 1 Receptor
27%
Beta Cell
27%
Cholecystokinin Receptor
27%
Arm Bone
27%
Cohort Effect
27%
Diabetic Obesity
27%
Disease Management
27%
Diagnosis
27%
Glucagon-Like Peptide-1 Agonist
27%
Comorbidity
27%
Proteomics
27%
Proteomics
27%
Retrospective Study
27%
Type 2 Diabetes
22%
Glucose Metabolism
18%
Hemoglobin A1c
17%
Cholecystokinin A Receptor
13%
Glucagon
13%
Satiety
13%
Peptide Hormone
9%
Pancreas Polypeptide
9%
Hormone Receptor
9%
Somatostatin
9%
Cell Survival
9%
Biological Activity
9%
Blood Glucose
9%
Ghrelin
9%
Small Intestine
9%
Energy Expenditure
9%
Secretion (Process)
9%
Natriuretic Factor
9%
Biological Marker
8%
Medicine
6%